These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27804122)

  • 41. [Metabolic modifications related to immunosuppressive drugs].
    Ducobu J
    Rev Med Brux; 2002 Jun; 23(3):156-9. PubMed ID: 12143154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation?
    Bond MMK; Bond MMK; Sehn A; Dias VH; Said TL; Dos Santos CC; Finger MA; Santos AMG; Neto JMR
    Transplant Proc; 2018 Apr; 50(3):809-814. PubMed ID: 29661443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors].
    Nikitin AV
    Antibiot Khimioter; 2014; 59(1-2):44-7. PubMed ID: 25051716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcineurin inhibitors in heart transplantation.
    Keogh A
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice.
    Oetjen E; Baun D; Beimesche S; Krause D; Cierny I; Blume R; Dickel C; Wehner S; Knepel W
    Mol Pharmacol; 2003 Jun; 63(6):1289-95. PubMed ID: 12761338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?
    Wong W; Venetz JP; Tolkoff-Rubin N; Pascual M
    Transplantation; 2005 Aug; 80(3):289-96. PubMed ID: 16082321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory T-Cell Augmentation or Interleukin-17 Inhibition Prevents Calcineurin Inhibitor-Induced Hypertension in Mice.
    Chiasson VL; Pakanati AR; Hernandez M; Young KJ; Bounds KR; Mitchell BM
    Hypertension; 2017 Jul; 70(1):183-191. PubMed ID: 28584011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of ketoconazole combined with calmodulin inhibitor in solid organ transplantation: A systematic review and meta-analysis.
    Xue T; Yang T; Chen C; Wu S; Li M; Ma L; Zhou Y; Cui Y
    J Clin Pharm Ther; 2020 Feb; 45(1):29-34. PubMed ID: 31571253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcineurin inhibitors target Lck activation in graft-versus-host disease.
    Carter NM; Pomerantz JL
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment.
    Baran DA; Galin ID; Gass AL
    Am J Cardiovasc Drugs; 2004; 4(1):21-9. PubMed ID: 14967063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Kronbichler A; Neumann I; Mayer G
    Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tacrolimus-induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin.
    Gratreak BDK; Swanson EA; Lazelle RA; Jelen SK; Hoenderop J; Bindels RJ; Yang CL; Ellison DH
    Physiol Rep; 2020 Jan; 8(1):e14316. PubMed ID: 31908154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats.
    Kanda J; Izumo N; Furukawa M; Shimakura T; Yamamoto N; E Takahashi H; Asakura T; Wakabayashi H
    Biomed Res; 2018; 39(3):131-139. PubMed ID: 29899188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects-A Review of Literature.
    Surówka A; Prowans P; Żołnierczuk M; Miśkiewicz M; Wawrowski T; Skodda M; Markowska M; Kędzierska-Kapuza K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New immunosuppressive drugs and diabetes].
    Legendre C; Thervet E; Bédrossian J
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):172-6. PubMed ID: 11353885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
    Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
    Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of the inhibition of IL-2 production by calcineurin inhibitors.
    van den Berg AP; van Son WJ; Haagsma EB; The TH; Slooff MJ; de Leij LM
    Transplant Proc; 2001; 33(1-2):1076-7. PubMed ID: 11267197
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
    Karie-Guigues S; Janus N; Saliba F; Dumortier J; Duvoux C; Calmus Y; Lorho R; Deray G; Launay-Vacher V; Pageaux GP
    Liver Transpl; 2009 Sep; 15(9):1083-91. PubMed ID: 19718632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From the Clinical to the Bench: Exploring the Insulin Modulation Effects of Tacrolimus and Belatacept.
    Perrier Q; Cottet-Rouselle C; de-Beaumont M; Noble J; Lablanche S
    Cell Transplant; 2024; 33():9636897241246577. PubMed ID: 38646716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.